Use of biologics for the management of Crohn's disease: IG-IBD technical review based on the GRADE methodology

被引：2

作者：

Bonovas, Stefanos ^{[1
,2
]}

Piovani, Daniele ^{[1
,2
]}

Pansieri, Claudia ^{[1
,2
]}

Macaluso, Fabio Salvatore ^{[3
]}

Orlando, Ambrogio ^{[3
]}

Festa, Stefano ^{[4
]}

Papi, Claudio ^{[4
]}

Pugliese, Daniela ^{[5
]}

Armuzzi, Alessandro ^{[1
,6
]}

机构：

[1] Humanitas Univ, Dept Biomed Sci, Via R Levi Montalcini 4, I-20072 Milan, Italy

[2] IRCCS Humanitas Res Hosp, Milan, Italy

[3] Villa Sofia Cervello Hosp, IBD Unit, Palermo, Italy

[4] San Filippo Neri Hosp, IBD Unit, Rome, Italy

[5] Policlin Univ A Gemelli IRCCS Fdn, Dept Med & Surg Sci, Div Internal Med & Gastroenterol, Rome, Italy

[6] IRCCS Humanitas Res Hosp, IBD Ctr, Milan, Italy

来源：

DIGESTIVE AND LIVER DISEASE | 2023年 / 55卷 / 06期

关键词：

Crohn's disease; Guidelines; GRADE; MAINTENANCE THERAPY; INFLIXIMAB MAINTENANCE; JAPANESE PATIENTS; ADALIMUMAB; INDUCTION; METAANALYSIS; USTEKINUMAB; VEDOLIZUMAB; REMISSION; AZATHIOPRINE;

D O I：

10.1016/j.dld.2023.02.019

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The therapeutic armamentarium for the management of Crohn's disease (CD) is rapidly expanding. Sev-eral biologic therapies (e.g. infliximab, adalimumab, vedolizumab, and ustekinumab) have been regulatory approved, and there is considerable practice variability in the treatment of patients with CD. This technical review systematically searched and identified the current evidence, synthesized it using meta-analytic methodology, appraised its quality, and concisely presented it, thus forming the basis for developing clinical practice recommendations on the use of biologic treatments in adult patients with CD. (c) 2023 The Author(s). Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.

引用

页码：695 / 703

页数：9

共 50 条

[41] Use of helminth therapy for management of ulcerative colitis and Crohn's disease: a systematic review
Shields, Victoria Emma
Cooper, Jan
PARASITOLOGY, 2022, 149 (02) : 145 - 154
[42] Modern Management of Perianal Crohn's Disease: A Review
Williams, Jennifer L.
Shaffer, Virginia O.
AMERICAN SURGEON, 2021, 87 (09) : 1361 - 1367
[43] Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriateness
Juillerat, Pascal
Pittet, Valerie
Vader, John-Paul
Burnand, Bernard
Gonvers, Jean-Jacques
de Saussure, Philippe
Mottet, Christian
Seibold, Frank
Rogler, Gerhard
Sagmeister, Markus
Felley, Christian
Michetti, Pierre
Froehlich, Florian
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (11) : 1352 - 1357
[44] Placebo-Controlled Trials in the Management of Crohn's Disease: An Umbrella Review of Meta-Analyses
Silva, Richard
de Azevedo, Jose Nunes
Machado, Jorge Pereira
Rodrigues, Jorge Magalhaes
MEDICAL SCIENCES, 2025, 13 (01)
[45] The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus
Macaluso, Fabio Salvatore
Caprioli, Flavio
Benedan, Laura
Bezzio, Cristina
Caporali, Roberto
Cauli, Alberto
Chimenti, Maria Sole
Ciccia, Francesco
D'Angelo, Salvatore
Fantini, Massimo Claudio
Festa, Stefano
Iannone, Florenzo
Lubrano, Ennio
Mariani, Paolo
Papi, Claudio
Provenzano, Giuseppe
Pugliese, Daniela
Rispo, Antonio
Saibeni, Simone
Salvarani, Carlo
Variola, Angela
Zenga, Mariangela
Armuzzi, Alessandro
Orlando, Ambrogio
Gerli, Roberto
AUTOIMMUNITY REVIEWS, 2024, 23 (05)
[46] The use of exclusive enteral nutritional therapy in children and adolescents with active Crohn's disease: an integrative review
Vidal, Helen Cristina
Rogero, Marcelo Macedo
NUTRIRE, 2022, 47 (02)
[47] Comparative Efficacy of Novel Biologics, Anti-tumor Necrosis Factor Agents, and Immunomodulators to Prevent Postoperative Recurrence in Crohn's Disease: A Systematic Review and Network Meta-analysis
Duan, Shihao
Chen, Pingrun
Liang, Chang
Zhang, Yan
JOURNAL OF CROHNS & COLITIS, 2024, 19 (02)
[48] Perception and clinical decisions from inflammatory bowel diseases' specialists towards positioning of new therapies in Crohn's disease and ulcerative colitis: A national web-based survey from the Brazilian IBD study group (GEDIIB)
Romero, Roberta Krause
Magro, Daniela Oliveira
Queiroz, Natalia Sousa Freitas
Damiao, Aderson Omar Mourao Cintra
Teixeira, Fabio Vieira
Nones, Rodrigo Bremer
Sassaki, Ligia Yukie
Saad-Hossne, Rogerio
Kotze, Paulo Gustavo
GASTROENTEROLOGIA Y HEPATOLOGIA, 2022, 45 (07): : 499 - 506
[49] Model-Based Meta-Analysis on the Efficacy of Biologics and Small Targeted Molecules for Crohn's Disease
Yu, Boran
Zhao, Libo
Jin, Siyao
He, Huan
Zhang, Jing
Wang, Xiaoling
FRONTIERS IN IMMUNOLOGY, 2022, 13
[50] Surgical management of Crohn’s disease: a state of the art review
Elise Maria Meima - van Praag
Christianne Johanna Buskens
Roel Hompes
Wilhelmus Adrianus Bemelman
International Journal of Colorectal Disease, 2021, 36 : 1133 - 1145

← 1 2 3 4 5 →